Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
See Latest ArticlesPhysical activity and exercise dependence during inpatient treatment of longstanding eating disorders: An exploratory study of excessive and non-excessive exercisers
International Journal of Eating Disorders, 10/20/09
Bratland–Sanda S et al. – Excessive exercise is an important issue in longstanding ED, and the excessive exercising patients need help to develop alternative strategies to regulate negative affects.
Today in Eating Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
The Outcome of Bulimia Nervosa: Findings From One-Quarter Century of Research
American Journal of Psychiatry, 11/06/09
Randomized Controlled Clinical Trial of Yoga in the Treatment of Eating Disorders
Journal of Adolescent Health, 11/04/09
Increased suppression of serum ghrelin concentration by hyperinsulinemia in women with anorexia nervosa
European Journal of Endocrinology, 11/05/09
Today in Other Psychiatry...keeping you current
Receive free subspecialty "5-minute updates" via email
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/28/09
Is Monotherapy as Good as Polypharmacy in Long-Term Treatment of Bipolar Disorder
Canadian Journal of Psychiatry, 11/16/09
Asenapine versus olanzapine in acute mania: a double-blind extension study
Bipolar Disorders, 10/22/09
Today in Personality Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Estimation of clonazepam abuse liability: a new method using a reimbursed drug database
International Clinical Psychopharmacology, 10/20/09
Impulsivity, personality and bipolar disorder
European Psychiatry , 11/06/09
Open-label study of high (30 mg) and moderate (20 mg) dose escitalopram for the treatment of obsessive-compulsive disorder
International Clinical Psychopharmacology, 10/23/09
Sponsor
Article Search
Sponsor